Comparison |
Alternate Manufacturer Number |
| 2630523 | 3549813 | | 2630507 |
Alternate Packaging |
EA/1 | | CT/5 | EA/1 | |
Country of Origin |
Italy | Unknown | Unknown | Italy | Unknown |
Generic Drug Name |
Verapamil HCl, Preservative Free | Verapamil HCl | Verapamil HCl, Preservative Free | Verapamil HCl, Preservative Free | Verapamil HCl |
NDC Number |
51662139803 | 70756060605 | 51754020302 | 51662126903 | 70756060505 |
Strength |
2.5 mg / mL | 2.5 mg / 1 mL | 2.5 mg / mL | 2.5 mg / mL | 2.5 mg / 1 mL |
UNSPSC Code |
51431614 | 51431614 | 51431609 | 51431614 | 51431614 |
Volume |
4 mL | 4 mL | 2 mL | 2 mL | 2 mL |
Application |
Calcium-Channel Blocking Agent | Calcium-Channel Blocking Agent | Calcium-Channel Blocking Agent | Calcium-Channel Blocking Agent | Calcium-Channel Blocking Agent |
Container Type |
Single-Dose Vial | Single-Dose Vial | Single-Dose Vial | Single-Dose Vial | Single-Dose Vial |
Dosage Form |
Injection | Injection | Injection | Injection | Injection |
Generic Drug Code |
01650 | 01650 | 01650 | 01650 | 01650 |
Product Dating |
McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days |
Type |
Intravenous | Intravenous | Intravenous | Intravenous | Intravenous |
Features and Benefits |
- Single dose glass flip-top vial
|
|
- 5 single dose vials per carton
- Verapamil hydrochloride is a calcium antagonist or slow-channel inhibitor
- The solution contains no bacteriostat or antimicrobial agent and is intended for single-dose intravenous administration
- The antiarrhythmic effect of verapamil appears to be due to its effect on the slow channel in cells of the cardiac conduction system
- The vasodilatory effect of verapamil appears to be due to its effect on blockade of calcium channels as well as receptors
|
- Verapamil hydrochloride is a calcium antagonist or slow-channel inhibitor
- The solution contains no bacteriostat or antimicrobial agent and is intended for single-dose intravenous administration
- The antiarrhythmic effect of verapamil appears to be due to its effect on the slow channel in cells of the cardiac conduction system
- The vasodilatory effect of verapamil appears to be due to its effect on blockade of calcium channels as well as receptors
|
|